ZEISS Medical Technology and Boehringer Ingelheim, a German-based bio-pharmaceutical group with operating in the Human Pharma and Animal Health markets, have announced the signature of a long-term strategic agreement. The partnership is aimed at developping predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.